Company Overview and News

 
Barron's: Delta, Goodyear stock have more upside than prices suggest

4h reuters
April 22 (Reuters) - Delta Air Lines, Goodyear Tire & Rubber and Lincoln National Corp may have more upside than their discounted share prices suggest, Barron’s reported.
Upvote Downvote

 
China's stock market shedding its casino reputation

4h nzherald.co.nz
Dismissed by many as a casino after its wild boom and bust in 2015, the country's $7.6 trillion equity market has quietly turned into a place where fundamentals matter. Chinese shares with the most attractive dividends, profit revisions and earnings yields - metrics used by Wall Street pros for decades - have trounced the nation's benchmark index by as much as 46 percentage points over the past three years, according to data compiled by Bloomberg.
Upvote Downvote

 
Latest Morgan Stanley Broker Gag Effort Moves to Arbitration

4h advisorhub
A New Jersey broker sued on Tuesday by Morgan Stanley to inhibit his ability to call former customers at his new employer has agreed to sign an affidavit attesting that he does not possess customer lists or other documents or computerized data owned by the wirehouse.
Upvote Downvote

 
Amazon to double down on groceries; foray deeper into fresh produce in India

4h reuters
BENGALURU (Reuters) - Amazon.com Inc expects groceries and household products to account for over half of its business in India in the next five years, as it moves to broaden offerings in the segment and foray into areas such as fresh produce.
Upvote Downvote

 
Interview: Amazon to double down on groceries; foray deeper into fresh produce in India - Channel NewsAsia

4h channelnewsasia
BENGALURU: Amazon.com Inc expects groceries and household products to account for over half of its business in India in the next five years, as it moves to broaden offerings in the segment and foray into areas such as fresh produce.
Upvote Downvote

1
Watch AMD Institutional Investors' Trades

5h seekingalpha
Five large institutional investors were accumulating AMD shares when share prices were dropping and shares were heavily shorted. They also sold shares into an upward price trend.
Upvote Downvote

 
The Man Who Could Eat Half the Profit in Fund Management - Bloomberg

7h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
IPO News This Week: DocuSign Tops List of 6 Scheduled Offerings

9h 247wallst
Last week’s initial public offering (IPO) calendar included eight firms looking to enter the public markets. Only five succeeded. The coming week includes six firms seeking about $1.3 billion in new capital from the public markets.
Upvote Downvote

 
Cadaret Grant acquired by private-equity-backed Atria

11h investmentnews
A quarterly report on the trends and ideas that advisers who serve retirement plan sponsors and participants care about.
Upvote Downvote

 
Is Investors’ Love Affair with Apple Over?

12h 247wallst
The worst-performing stock among the Dow 30 on Friday was Apple Inc. (NASDAQ: AAPL). The shares dropped 4.1% on the day and more than 5% for the week. Only IBM and P&G had a worse week
Upvote Downvote

 
The latest victims of the Amazon effect: The Kardashians - MarketWatch

14h marketwatch
Did the “Amazon effect” play more than a cameo role in the Kardashians’ decision to shutter their chain of boutiques?
Upvote Downvote

 
Stocks To Watch: Earnings Blockbusters And Trump Talks Drug Prices

2018-04-21 seekingalpha
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
Upvote Downvote

 
What’s changing at China’s central bank under its new leadership?

2018-04-21 scmp
The new leadership team at China’s central bank may be starting the long overdue process of fixing monetary policy problems and taking a fresh approach to balancing growth and risk control.
Upvote Downvote

 
In a Volatile 1st Quarter, CME Group Might Be the Big Winner

2018-04-21 zacks
The first quarter of the year was a real roller coaster ride in the U.S. equity markets. A big run-up in January was followed by an even bigger slide in February. After peaking at 2782 on January, the S&P 500 index plunged to 2581 on February 8th. Unfortunately, the nauseating ride wasn’t over and we saw several more large daily moves throughout February and March that helped move the CBOE volatility index (VIX - the market’s “fear gauge”) to a peak of 37 – a multi-year high.
Upvote Downvote

 
Wall Street falls on investor nerves about interest rates, tech

2018-04-21 moneycontrol
Wall Street’s three major indexes declined on Friday as investors worried about a jump in US bond yields, with technology stocks leading the decline on nerves about upcoming earnings reports and iPhone demand.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 617446448